323 filings
Page 6 of 17
4
deVries Tina Marie
20 May 22
RVL Pharmaceuticals / Tina Marie deVries ownership change
4:28pm
4
RVLPQ
RVL Pharmaceuticals plc
20 May 22
RVL Pharmaceuticals / Christopher Klein ownership change
4:27pm
4
Schaub James
20 May 22
RVL Pharmaceuticals / James Schaub ownership change
4:25pm
10-Q
2022 Q1
RVLPQ
RVL Pharmaceuticals plc
Quarterly report
12 May 22
4:44pm
8-K
RVLPQ
RVL Pharmaceuticals plc
12 May 22
RVL Pharmaceuticals plc Reports First Quarter 2022 Financial Results; Provides Commercial Update
7:17am
DEFA14A
RVLPQ
RVL Pharmaceuticals plc
25 Apr 22
Additional proxy soliciting materials
4:17pm
DEF 14A
RVLPQ
RVL Pharmaceuticals plc
Definitive proxy
25 Apr 22
4:15pm
3
Michael DePetris
22 Apr 22
RVL Pharmaceuticals / Michael DePetris ownership change
4:15pm
PRE 14A
RVLPQ
RVL Pharmaceuticals plc
Preliminary proxy
12 Apr 22
5:04pm
8-K
RVLPQ
RVL Pharmaceuticals plc
11 Apr 22
Departure of Directors or Certain Officers
4:33pm
8-K
RVLPQ
RVL Pharmaceuticals plc
6 Apr 22
RVL Pharmaceuticals plc Announces Preliminary First Quarter 2022 UPNEEQ® Net Product Sales Results
9:04am
8-K
RVLPQ
RVL Pharmaceuticals plc
4 Apr 22
Entry into a Material Definitive Agreement
4:15pm
10-K
2021 FY
RVLPQ
RVL Pharmaceuticals plc
Annual report
30 Mar 22
4:48pm
8-K
RVLPQ
RVL Pharmaceuticals plc
30 Mar 22
Fourth quarter 2021 UPNEEQ product sales of $3.1 million, representing 39% growth over third quarter sales
4:16pm
4
Einhorn Andrew J.
26 Jan 22
RVL Pharmaceuticals / Andrew J. Einhorn ownership change
4:31pm
4
Klein Christopher
26 Jan 22
RVL Pharmaceuticals / Christopher Klein ownership change
4:31pm
4
deVries Tina Marie
26 Jan 22
RVL Pharmaceuticals / Tina Marie deVries ownership change
4:31pm
4
Schaub James
26 Jan 22
RVL Pharmaceuticals / James Schaub ownership change
4:30pm
8-K
RVLPQ
RVL Pharmaceuticals plc
19 Jan 22
Results of Operations and Financial Condition
7:07am
8-K
RVLPQ
RVL Pharmaceuticals plc
18 Jan 22
Amendments to Articles of Incorporation or Bylaws
8:16am